Uncovers survival-linked gene modules in ovarian cancer, suggesting new treatment targets.
The molecular characterisation of high-grade serous ovarian cancer (HGSC) in exceptionally long- or short-term survivors has the potential to reveal novel prognostic biomarkers and clinically actionable targets.
No takes yet. Share an insight, caveat, or question.
Werner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: